Context Therapeutics Inc. (CNTX)
NASDAQ·Healthcare·Biotechnology
$2.35
-6.37%
Mkt Cap $215.00M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$5.25
Range $4.50 – $6.00
Implied Upside
+123.4%
Consensus $5.25 vs current $2.35
NASDAQ·Healthcare·Biotechnology
$2.35
-6.37%
Mkt Cap $215.00M
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$5.25
Range $4.50 – $6.00
+123.4%
Consensus $5.25 vs current $2.35